Medical Marijuana, Inc, (OTCMKTS:MJNA), subsidiary Phyto Animal Health Reveals Veterinarian-Exclusive CBD Product at 90th WVC Veterinary Conference in Las Vegas
Having strongly made its entry into the market (post legalization), various research companies have invested enormous resources in exploring every possible benefit marijuana can bring in the products and different sectors of the economy.
Having numerous natural benefits, hemp-derived CBD supplements provide non-psychoactive, non-toxic and tolerable thereby providing the best supplement option for both human and animals.
Medical Marijuana, Inc, (OTCMKTS:MJNA) aims to be the most precious cannabis and hemp product innovator through building a team of professionals to help in sourcing, evaluating and acquiring likeminded companies and products.
Through its subsidiary, it has been the latest researchers to release their new research product the VITALITY 1700 mg CBD Oral Concentrate which helps pets be able to rest comfortably
This comes amidst outcry for national shortages in the opioid medications which has made it challenging for both animals and human beings pain management thereby resulting to clinicians opting for natural alternatives.
THE MORNING REPORT
Start your workday the right way with the news that matters most.
Your information is 100% secure with us and will never be shared Disclaimer & Privacy Policy
Being a regional leader, medical marijuana has continued to acquire new stakes in companies within the sector with an aim to expand its base in the market while continuing to capitalize on its research capacities
AXIM Biotechnologies Inc (OTCMKTS:AXIM) being Medical Marijuana’s major investment successfully executed their first-ever extraction methodology’s in proprietary current good manufacturing practices (cGMP)
AXIM’s new methods sets precedence over the nature of the processes that were being used in the past from the growth of cannabis through to extraction and manufacturing leading to the most available standards.
The company has placed its focus on research’s, development and production of cannabinoid-based pharmaceuticals, nutraceuticals and cosmetic products
Besides supporting entrepreneurial developments, Medical marijuana has enabled and facilitated great innovations and research throughout its investments and established partners.
New companies have also promised new innovations that aim to harness the benefits of cannabis for use by clinicians in the processes of patient management and other industrial purposes that aim to add value in their process chains
Cannabis usage has however come alongside stringent regulations that aims to tame its misuse thereby leading to introduction of more and more certifications for all prospective participants in the sector.
